Depression and depressive symptoms in patients with polymyalgia rheumatica: discussion points, grey areas and unmet needs emerging from a systematic review of published literature

Documenti analoghi

• Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature
  di: Ciro Manzo, et al.
  Pubblicazione: (2020-11-01)
• Identification and Classification of Polymyalgia Rheumatica (PMR) and PMR-Like Syndromes Following Immune Checkpoint Inhibitors (ICIs) Therapy: Discussion Points and Grey Areas Emerging from a Systematic Review of Published Literature
  di: Manzo, Ciro, et al.
  Pubblicazione: (2020)
• Polymyalgia Rheumatica (PMR) and Polymyalgia Rheumatica-like (PMR-like) Manifestations in Cancer Patients Following Treatment with Nivolumab and Pembrolizumab: Methodological Blurred Points Identified Through a Systematic Review of Published Case Reports
  di: Ciro Manzo, et al.
  Pubblicazione: (2025-04-01)
• Back to the future: identification and classification of polymyalgia rheumatica and polymyalgia rheumatica-like syndromes following cancer immunotherapy with checkpoint inhibitors
  di: Manzo, Ciro, et al.
  Pubblicazione: (2021)
• Polymyalgia rheumatica with normal inflammatory indices at the time of diagnosis: can we just move a step forward?
  di: Manzo, Ciro, et al.
  Pubblicazione: (2020)